ATE461201T1 - Prozess zur herstellung eines kristallinen polymorphs eines die plättchen aggregation hemmenden arzneistoffs - Google Patents

Prozess zur herstellung eines kristallinen polymorphs eines die plättchen aggregation hemmenden arzneistoffs

Info

Publication number
ATE461201T1
ATE461201T1 AT04743729T AT04743729T ATE461201T1 AT E461201 T1 ATE461201 T1 AT E461201T1 AT 04743729 T AT04743729 T AT 04743729T AT 04743729 T AT04743729 T AT 04743729T AT E461201 T1 ATE461201 T1 AT E461201T1
Authority
AT
Austria
Prior art keywords
mixture
type solvent
sulfuric acid
polymorph form
clopidogrel
Prior art date
Application number
AT04743729T
Other languages
English (en)
Inventor
Nagy Peter Kotay
Gyula Simig
Jozsef Barkoczy
Tamas Gregor
Bela Farkas
Donath Gyoergyi Vereczkeyne
Kalman Nagy
Gyulane Koertvelyessy
Zsuzsanna Szent-Kirallyi
Original Assignee
Egis Gyogyszergyar Nyilvanosan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU0302028A external-priority patent/HU0302028D0/hu
Priority claimed from HU0401272A external-priority patent/HU226773B1/hu
Application filed by Egis Gyogyszergyar Nyilvanosan filed Critical Egis Gyogyszergyar Nyilvanosan
Application granted granted Critical
Publication of ATE461201T1 publication Critical patent/ATE461201T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT04743729T 2003-07-02 2004-06-30 Prozess zur herstellung eines kristallinen polymorphs eines die plättchen aggregation hemmenden arzneistoffs ATE461201T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0302028A HU0302028D0 (en) 2003-07-02 2003-07-02 Process for the production of crystalline polymorphous form of an anticoagulant agent
HU0401272A HU226773B1 (en) 2004-06-23 2004-06-23 Process for the production of clopidogrel hydrogensulfate polymorph 1
PCT/HU2004/000070 WO2005003139A1 (en) 2003-07-02 2004-06-30 Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug

Publications (1)

Publication Number Publication Date
ATE461201T1 true ATE461201T1 (de) 2010-04-15

Family

ID=89985327

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04743729T ATE461201T1 (de) 2003-07-02 2004-06-30 Prozess zur herstellung eines kristallinen polymorphs eines die plättchen aggregation hemmenden arzneistoffs

Country Status (14)

Country Link
US (1) US20070142637A1 (de)
EP (1) EP1644381B1 (de)
JP (1) JP4681545B2 (de)
KR (1) KR101155679B1 (de)
CN (1) CN1812993B (de)
AT (1) ATE461201T1 (de)
BG (1) BG109429A (de)
CA (1) CA2530449C (de)
CZ (1) CZ200641A3 (de)
DE (1) DE602004026059D1 (de)
EA (1) EA010684B1 (de)
PL (2) PL378710A1 (de)
SK (1) SK50102006A3 (de)
WO (1) WO2005003139A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005100364A1 (en) * 2004-04-19 2005-10-27 Krka, Tovarna Zdravil, D.D. Novo Mesto Processes for the preparation of clopidogrel hydrogen sulfate polymorphic form i
WO2007032023A2 (en) * 2005-07-12 2007-03-22 Rpg Life Sciences Limited A process for preparation of methyl-(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h)-acetic acid methyl ester or salts thereof having higher chiral purity and products thereof
EP1931682A2 (de) * 2006-08-03 2008-06-18 Teva Pharmaceutical Industries Ltd. Verfahren zur herstellung von clopidogrel-bisulphat
WO2011010318A1 (en) * 2009-07-23 2011-01-27 Praveen Laboratories Private Limited Process for the preparation of clopidogrel polymorphous form 1 using seed chrystals
CN102070648A (zh) * 2010-12-07 2011-05-25 天津红日药业股份有限公司 I型硫酸氢氯吡格雷的制备方法
CN102702224A (zh) * 2012-06-25 2012-10-03 山东齐都药业有限公司 I型硫酸氢氯吡格雷的制备方法
CN107337683B (zh) * 2017-08-16 2019-08-16 中荣凯特(北京)生物科技有限公司 一种噻吩并吡啶类衍生物硫酸氢盐的晶型ⅱ及其制备方法和应用
CN113121559B (zh) * 2019-12-31 2023-08-29 惠州信立泰药业有限公司 一种高堆密度的ii型硫酸氢氯吡格雷球形结晶及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2779726B1 (fr) * 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
MXPA03006133A (es) * 2001-01-24 2004-05-04 Cadila Healthcare Ltd Proceso para preparar clopidogrel.
GB0125708D0 (en) * 2001-10-26 2001-12-19 Generics Uk Ltd Novel compounds and processes
MXPA04006088A (es) * 2001-12-18 2004-09-27 Teva Pharma Polimorfo de sulfato de hidrogeno de clopidogrel.

Also Published As

Publication number Publication date
SK50102006A3 (sk) 2006-05-04
CZ200641A3 (cs) 2006-05-17
EP1644381B1 (de) 2010-03-17
WO2005003139A1 (en) 2005-01-13
EP1644381A1 (de) 2006-04-12
PL1644381T3 (pl) 2010-08-31
US20070142637A1 (en) 2007-06-21
JP4681545B2 (ja) 2011-05-11
EA200600138A1 (ru) 2006-08-25
CA2530449C (en) 2010-03-23
PL378710A1 (pl) 2006-05-15
CA2530449A1 (en) 2005-01-13
KR20060026119A (ko) 2006-03-22
DE602004026059D1 (de) 2010-04-29
BG109429A (en) 2006-10-31
JP2007516167A (ja) 2007-06-21
CN1812993A (zh) 2006-08-02
EA010684B1 (ru) 2008-10-30
KR101155679B1 (ko) 2012-06-13
CN1812993B (zh) 2011-06-29

Similar Documents

Publication Publication Date Title
US20100204268A1 (en) Processes for preparing different forms of (s)-(+)-clopidogrel bisulfate
DE69022943D1 (de) Verfahren zur Herstellung von Phenylessigsäurederivaten aus Thienopyridin und Zwischenprodukte von alpha-Bromphenylessigsäuren.
ATE461201T1 (de) Prozess zur herstellung eines kristallinen polymorphs eines die plättchen aggregation hemmenden arzneistoffs
DE602008005461D1 (de) Verfahren zur herstellung von essigsäure-5-ä2-cyclopropyl-1-(2-fluorphenyl)-2-oxoethylü-4,5,6,7-tetrahydrothienoä3,2-cüpyridin-2-yl-ester (prasugrel)
ATE411998T1 (de) Verfahren zur herstellung der kristallform i von clopidogrel-hydrogensulphat
RU2011139325A (ru) Аморфная соль макроциклического ингибитора hcv
AR048272A1 (es) Sintesis de 2 metil - 4- (4- metil -1- piperazinil) - 10 h- tieno ( 2,3-b) (1,5) benzodiazepina y sus sales, metodos para su preparacion, composiciones farmaceuticas que la contienen y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades mentales.
DE4107521A1 (de) Neue acylaminosubstituierte hetrazepine
WO2004094374A2 (en) Preparation of (s)-clopidogrel and related compounds
WO2006087729B1 (en) Rapid resolution process for clopidogrel base and a process for preparation of clopidogrel bisulfate polymorph - form i
JP2014524929A (ja) プラスグレルの調製方法
CN103319499B (zh) 二噻吩并[2,3-b:2′,3′-d]噻吩的制备方法
WO2004048385A3 (en) A process for the preparation of crystalline form 1 or clopidogrel hydrogen sulfate
CN104672258A (zh) 一种含双键水溶性钆配合物及其合成方法和应用
EA200801963A1 (ru) СПОСОБ ПОЛУЧЕНИЯ ПОЛИМОРФНОЙ ФОРМЫ I ГИДРОСУЛЬФАТА (S)-(+)-МЕТИЛ-α-(2-ХЛОРФЕНИЛ)-6,7-ДИГИДРОТИЕНО-[3,2-C] ПИРИДИН-5(4H)-АЦЕТАТА
HUP0401272A2 (hu) Eljárás clopidogrel-hidrogénszulfát kristályos polimorf módosulatának előállítására
DE69500481D1 (de) Verfahren zur Herstellung von N-Chloracetylglutamin
US20120232274A1 (en) Process for preparation of clopiodogrel bisulfate form-1
CN103910721A (zh) 一种氨曲南的制备方法
WO2008068569A2 (en) Processes for the preparation of clopidogrel hydrochloride
CA2488325A1 (en) Improved process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
JP2005509011A5 (de)
EP2089396B1 (de) Verfahren zur herstellung von (s)-(+)-clopidogrelbase und deren salzen
BRPI0621138A2 (pt) processo para a preparação de s-(+)-clopidogrel
WO2007032023A8 (en) A process for preparation of methyl-(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h)-acetic acid methyl ester or salts thereof having higher chiral purity and products thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties